Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
about
HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesisActivin receptor-like kinases: a diverse family playing an important role in cancerA stable explant culture of HER2/neu invasive carcinoma supported by alpha-Smooth Muscle Actin expressing stromal cells to evaluate therapeutic agentsFollistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42Rank-rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures.Proteomic characterization of Her2/neu-overexpressing breast cancer cells.Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumorsKrüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.Pharmacological strategies to overcome HER2 cross-talk and Trastuzumab resistance.Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression.Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancerIdentification of mouse MARVELD1 as a microtubule associated protein that inhibits cell cycle progression and migration.Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.TPD52 represents a survival factor in ERBB2-amplified breast cancer cells.Biological features of core networks that result from a high-fat diet in hepatic and pulmonary tissues in mammary tumour-bearing, obesity-resistant mice.LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling.Activin Signaling and Its Role in Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis
P2860
Q24598092-353C56E9-0AFC-4955-A9AD-B689CE86EA10Q28066886-8F09FC20-A507-489F-B7D4-9F827C9280B8Q33330767-75B3B3F1-815A-4FE4-9B39-DA2FA3DC89B2Q33768293-B9CD0285-D185-4B2B-8914-C686E43F286FQ33795221-885C559D-7359-4522-BF54-C7CB56340FB2Q34121631-4D5AA40E-9532-4B21-8CE1-2EAB46433447Q34146410-53DBF56F-2E5A-423B-AB39-78D1B6503496Q35082856-C9BC3489-1FB3-4388-A014-1EE3E9BB4503Q35082931-734ADF15-31F5-4C48-96DE-71A983888D6EQ35095237-116F13F2-83AA-4465-A328-6E7BA8EC87E2Q35113788-9FADE876-EBE3-417F-B6BC-CF1736721FF8Q35803226-AF882400-F14E-4658-8999-0E37A2748BF4Q36177509-8A7794C2-4123-4C86-9E0F-FE782F139EB7Q36780754-4C211B1A-BE62-46B6-A7C2-65C5C87B38CBQ36926010-F2049A18-E786-49D9-982C-C356F4706917Q37599438-61B6C66E-3461-42B3-80A3-9AECF11223F7Q38209599-91CB00FC-3D34-4812-A25B-4C13969CA086Q38302448-03BE565E-7D06-4E2C-836C-5506200D7731Q38935156-320AC929-DD02-4708-AB03-BBFC77A129C0Q39153926-EF76E4F9-951E-451D-A278-CCBD54C58F60Q39227263-5ABD4F11-F7E7-47B4-9455-9E57BF2A3EF3Q39817827-8F2334EB-19CF-4588-A64D-3256DDE1F1A0Q47986499-576BDB62-BA4F-49D0-91EB-778C7D1AC2CFQ56518736-24F16E16-B252-4D95-BF5B-FAE3612129BB
P2860
Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Gene expression profiling of c ...... d tumors from transgenic mice.
@ast
Gene expression profiling of c ...... d tumors from transgenic mice.
@en
Gene expression profiling of c ...... d tumors from transgenic mice.
@nl
type
label
Gene expression profiling of c ...... d tumors from transgenic mice.
@ast
Gene expression profiling of c ...... d tumors from transgenic mice.
@en
Gene expression profiling of c ...... d tumors from transgenic mice.
@nl
prefLabel
Gene expression profiling of c ...... d tumors from transgenic mice.
@ast
Gene expression profiling of c ...... d tumors from transgenic mice.
@en
Gene expression profiling of c ...... d tumors from transgenic mice.
@nl
P2093
P2860
P356
P1433
P1476
Gene expression profiling of c ...... d tumors from transgenic mice.
@en
P2093
Darcie D Seachrist
David Danielpour
Marjorie E Montañez-Wiscovich
Melissa D Landis
Ruth A Keri
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208712
P407
P577
2005-08-01T00:00:00Z
P5875
P6179
1019287283